Recombinant zoster vaccine administration in an allergy/immunology practice: a medical and economic case

Thousands of US adults are killed by vaccine-preventable diseases each year,1 however, adult immunization rates in the US remain low, ranging from 8-64%.2 Increasing vaccination rates, and therefore preventing disease, requires an establishment of value by healthcare professionals and improved access to vaccinations.1 Allergists/immunologists should consider implementing routine vaccine administration for adolescents and adults into their practices. More than half of outpatient visits in the US are to specialists.
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Tags: Letters Source Type: research